DEXTROSE

DEXTROSE was reported 94265 times

DEXTROSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 123 0.8786
1 SLEEP DISORDER THERAPY 134 0.6768
2 APPENDICOLITH 253 0.6537
3 ANTACID THERAPY 79 0.6077
4 ANALGESIC THERAPY 129 0.4019
5 DRUG THERAPY 124 0.3658
6 VITAMIN B1 INCREASED 15 0.3191
7 CONGENITAL HIATUS HERNIA 66 0.2895
8 ANTICOAGULANT THERAPY 78 0.2746
9 MALIGNANT MELANOMA STAGE 0 53 0.2536
10 NEUROGLYCOPENIA 22 0.2000
11 DELIVERY 122 0.1851
12 BLOOD LACTIC ACID DECREASED 31 0.1802
13 CARDIAC OUTPUT INCREASED 30 0.1754
14 BACTEROIDES INFECTION 42 0.1609
15 BURKHOLDERIA TEST POSITIVE 19 0.1532
16 ELECTROCARDIOGRAM U WAVE PRESENT 9 0.1452
17 VITAMIN B1 DECREASED 36 0.1434
18 POLYGLANDULAR DISORDER 9 0.1324
19 HYPERPHOSPHATAEMIA 168 0.0781
20 GENITAL EROSION 22 0.0741
21 SOFT TISSUE MASS 34 0.0736
22 BLOOD PHOSPHORUS INCREASED 201 0.0735
23 GRANULOCYTE COUNT DECREASED 129 0.0695
24 DEHISCENCE 13 0.0688
25 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 60 0.0647
26 SPINAL MUSCULAR ATROPHY 17 0.0630
27 REFEEDING SYNDROME 9 0.0596
28 PERIPHERAL CIRCULATORY FAILURE 24 0.0585
29 MYELOSUPPRESSION 1855 0.0515
30 ANAEMIA FOLATE DEFICIENCY 9 0.0466
31 STOMA CLOSURE 14 0.0450
32 POSITIVE AIRWAY PRESSURE THERAPY 12 0.0411
33 HYPERDYNAMIC LEFT VENTRICLE 10 0.0407
34 NECROTISING SOFT TISSUE INFECTION 9 0.0390
35 OESOPHAGEAL PERFORATION 31 0.0372
36 MOTOR NEURONE DISEASE 18 0.0370
37 ELECTROCARDIOGRAM P WAVE ABNORMAL 9 0.0367
38 RENAL ISCHAEMIA 19 0.0347
39 SCROTAL ABSCESS 13 0.0344
40 CYTOTOXIC OEDEMA 9 0.0340
41 CSF PRESSURE INCREASED 9 0.0338
42 TOTAL LUNG CAPACITY DECREASED 53 0.0332
43 VITAMIN B1 DEFICIENCY 14 0.0328
44 RESPIRATORY TRACT INFECTION BACTERIAL 16 0.0321
45 NEONATAL INFECTION 11 0.0318
46 PO2 INCREASED 16 0.0316
47 MULTIPLE DRUG THERAPY 23 0.0305
48 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 32 0.0301
49 BLOOD URIC ACID INCREASED 165 0.0285
50 APPENDICITIS 263 0.0281
51 PCO2 INCREASED 20 0.0281
52 IRON DEFICIENCY 125 0.0278
53 PNEUMOCOCCAL SEPSIS 18 0.0274
54 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 138 0.0272
55 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 9 0.0263
56 HYPOPHOSPHATAEMIA 192 0.0260
57 MULTIMORBIDITY 31 0.0259
58 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 13 0.0254
59 VENTRICULAR FIBRILLATION 282 0.0254
60 GENITAL ABSCESS 10 0.0248
61 LIP EROSION 18 0.0247
62 MYASTHENIA GRAVIS 196 0.0242
63 AORTIC STENOSIS 83 0.0238
64 CARDIOGENIC SHOCK 339 0.0236
65 LUNG CONSOLIDATION 65 0.0232
66 MUCOSAL EROSION 21 0.0231
67 PERINEAL ABSCESS 10 0.0222
68 SUPERINFECTION 33 0.0220
69 LUNG OPACITY 54 0.0205
70 BLINDNESS CORTICAL 10 0.0204
71 CARDIOSPASM 11 0.0197
72 PLEURITIC PAIN 52 0.0188
73 FOETAL HEART RATE ABNORMAL 17 0.0184
74 NEPHROGENIC ANAEMIA 85 0.0183
75 ISCHAEMIC CEREBRAL INFARCTION 21 0.0181
76 RESPIRATORY SYMPTOM 48 0.0169
77 HYPERPARATHYROIDISM SECONDARY 42 0.0167
78 NASAL OBSTRUCTION 31 0.0165
79 KLEBSIELLA TEST POSITIVE 10 0.0154
80 EXTENSOR PLANTAR RESPONSE 14 0.0152
81 PALMOPLANTAR KERATODERMA 11 0.0152
82 TROPONIN INCREASED 115 0.0151
83 PREMATURE DELIVERY 235 0.0147
84 RETINAL ISCHAEMIA 9 0.0147
85 PERITONEAL CLOUDY EFFLUENT 20 0.0145
86 PERIARTHRITIS 33 0.0145
87 LYMPHADENECTOMY 14 0.0143
88 TRANSPLANT FAILURE 35 0.0143
89 SUPERFICIAL VEIN THROMBOSIS 12 0.0143
90 ANION GAP 9 0.0142
91 CARDIOVASCULAR INSUFFICIENCY 23 0.0141
92 BLOOD CHOLESTEROL DECREASED 26 0.0139
93 HYPERLACTACIDAEMIA 37 0.0138
94 BREATH SOUNDS ABNORMAL 68 0.0138
95 BLOOD BICARBONATE DECREASED 26 0.0137
96 DIABETES INSIPIDUS 32 0.0133
97 GASTRIC POLYPS 30 0.0133
98 MULTIPLE ORGAN DYSFUNCTION SYNDROME 370 0.0130
99 BLOOD PH DECREASED 22 0.0129
100 BRASH SYNDROME 18 0.0128
101 END STAGE RENAL DISEASE 233 0.0128
102 PERIRECTAL ABSCESS 14 0.0126
103 VASOPLEGIA SYNDROME 20 0.0122
104 NEUTROPHIL COUNT DECREASED 496 0.0122
105 ASCITES 356 0.0121
106 ACUTE LEFT VENTRICULAR FAILURE 8 0.0119
107 HYPOPARATHYROIDISM 9 0.0117
108 BRONCHIAL DISORDER 18 0.0116
109 MYOCARDIAL INJURY 13 0.0116
110 HYPERNATRAEMIA 56 0.0112
111 BENIGN PROSTATIC HYPERPLASIA 58 0.0112
112 BACTERIAL INFECTION 209 0.0112
113 EPIDIDYMITIS 13 0.0112
114 CHRONIC HEPATITIS 9 0.0111
115 BLOOD UREA ABNORMAL 10 0.0106
116 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 35 0.0106
117 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 180 0.0105
118 BLOOD SODIUM ABNORMAL 11 0.0103
119 OXYGEN SATURATION ABNORMAL 29 0.0102
120 HYPERLIPIDAEMIA 120 0.0100
121 BLOOD CALCIUM INCREASED 87 0.0099
122 RALES 57 0.0098
123 COLOUR BLINDNESS 9 0.0098
124 CALCULUS URINARY 15 0.0097
125 SPUTUM INCREASED 21 0.0097
126 RESUSCITATION 16 0.0096
127 BLOOD FIBRINOGEN DECREASED 11 0.0096
128 CLONUS 26 0.0095
129 TACHYPNOEA 128 0.0094
130 HYPOGLYCAEMIA NEONATAL 15 0.0093
131 EMBOLISM ARTERIAL 11 0.0092
132 MATERNAL EXPOSURE DURING DELIVERY 9 0.0091
133 ADMINISTRATION SITE EXTRAVASATION 9 0.0090
134 HYPERVOLAEMIA 44 0.0089
135 HEPARIN-INDUCED THROMBOCYTOPENIA 43 0.0087
136 TOXIC EPIDERMAL NECROLYSIS 131 0.0086
137 ENDOTRACHEAL INTUBATION 24 0.0086
138 HYPERPYREXIA 36 0.0085
139 HYPONATRAEMIA 478 0.0085
140 GLOMERULAR FILTRATION RATE ABNORMAL 12 0.0085
141 ACUTE LUNG INJURY 10 0.0084
142 HYPOGLYCAEMIA 406 0.0084
143 PRETERM PREMATURE RUPTURE OF MEMBRANES 10 0.0083
144 METHAEMOGLOBINAEMIA 19 0.0082
145 BICYTOPENIA 16 0.0082
146 BLOOD CHLORIDE INCREASED 14 0.0081
147 THROAT CLEARING 30 0.0080
148 INFLAMMATORY MARKER INCREASED 39 0.0079
149 FULL BLOOD COUNT ABNORMAL 83 0.0078
150 ATRIOVENTRICULAR BLOCK FIRST DEGREE 34 0.0078
151 INCREASED BRONCHIAL SECRETION 20 0.0078
152 STUPOR 25 0.0078
153 OPTIC NERVE INJURY 9 0.0078
154 NEURALGIA 186 0.0076
155 FUNGAEMIA 12 0.0076
156 LABELLED DRUG-DRUG INTERACTION ISSUE 11 0.0076
157 ANION GAP INCREASED 10 0.0075
158 PREMATURE BABY 224 0.0074
159 MECHANICAL VENTILATION 14 0.0074
160 ULCER 113 0.0071
161 ENDOCRINE DISORDER 9 0.0070
162 DEVICE INFUSION ISSUE 17 0.0068
163 BLOOD CREATINE INCREASED 30 0.0068
164 ASPIRATION 74 0.0067
165 ATRIAL TACHYCARDIA 14 0.0067
166 WHITE BLOOD CELL COUNT DECREASED 714 0.0066
167 INFUSION SITE EXTRAVASATION 41 0.0066
168 CHEST X-RAY ABNORMAL 20 0.0065
169 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 10 0.0065
170 COMPARTMENT SYNDROME 17 0.0065
171 INCORRECT DRUG ADMINISTRATION RATE 27 0.0063
172 BLOOD TEST ABNORMAL 89 0.0063
173 URINARY TRACT OBSTRUCTION 15 0.0063
174 GRANULOCYTOPENIA 36 0.0063
175 HYPERKALAEMIA 220 0.0063
176 NECROTISING FASCIITIS 22 0.0062
177 GOUT 111 0.0062
178 OPTIC ATROPHY 10 0.0061
179 NORMOCYTIC ANAEMIA 9 0.0061
180 RENAL TUBULAR NECROSIS 59 0.0060
181 BILIRUBIN CONJUGATED INCREASED 14 0.0060
182 FOETAL DEATH 31 0.0060
183 BODY TEMPERATURE ABNORMAL 11 0.0060
184 PULSE ABSENT 28 0.0059
185 ELECTROCARDIOGRAM ABNORMAL 46 0.0059
186 LEFT VENTRICULAR DYSFUNCTION 39 0.0058
187 JAUNDICE NEONATAL 11 0.0058
188 HYPERCHOLESTEROLAEMIA 56 0.0058
189 ACUTE RESPIRATORY FAILURE 111 0.0058
190 HEPATIC FUNCTION ABNORMAL 207 0.0055
191 DEVICE RELATED SEPSIS 11 0.0055
192 INTESTINAL ISCHAEMIA 30 0.0054
193 ACUTE RESPIRATORY DISTRESS SYNDROME 95 0.0054
194 RECTAL ABSCESS 9 0.0054
195 TRANSAMINASES INCREASED 118 0.0053
196 HYPOVOLAEMIA 31 0.0053
197 ATELECTASIS 51 0.0053
198 ACUTE KIDNEY INJURY 807 0.0053
199 SEPSIS 588 0.0053
200 HYPOPROTEINAEMIA 10 0.0053
201 LIVER INJURY 129 0.0053
202 BLOOD POTASSIUM ABNORMAL 14 0.0052
203 TUMOUR LYSIS SYNDROME 46 0.0052
204 HYPERREFLEXIA 18 0.0052
205 OBSTRUCTIVE AIRWAYS DISORDER 57 0.0051
206 MICTURITION URGENCY 58 0.0051
207 VOLVULUS 12 0.0051
208 BLOOD CHLORIDE DECREASED 13 0.0050
209 METABOLIC ENCEPHALOPATHY 15 0.0050
210 REBOUND ACID HYPERSECRETION 15 0.0050
211 HYPERTRIGLYCERIDAEMIA 29 0.0049
212 MOTOR DYSFUNCTION 50 0.0049
213 PUPILLARY REFLEX IMPAIRED 9 0.0049
214 DISTRIBUTIVE SHOCK 11 0.0049
215 HYPOXIA 169 0.0048
216 PROTEIN TOTAL DECREASED 18 0.0048
217 ELECTROENCEPHALOGRAM ABNORMAL 15 0.0047
218 ABDOMINAL INFECTION 12 0.0047
219 METABOLIC ACIDOSIS 150 0.0047
220 PRURITUS GENITAL 11 0.0047
221 OLIGURIA 29 0.0047
222 ENCEPHALOPATHY 113 0.0046
223 LACTIC ACIDOSIS 148 0.0046
224 MYOCARDIAL ISCHAEMIA 52 0.0046
225 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 9 0.0046
226 HYPERGLYCAEMIA 166 0.0046
227 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10 0.0045
228 MUSCLE CONTRACTIONS INVOLUNTARY 16 0.0045
229 LOW BIRTH WEIGHT BABY 36 0.0045
230 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
231 BLOOD UREA INCREASED 75 0.0045
232 KOUNIS SYNDROME 10 0.0044
233 CIRCULATORY COLLAPSE 75 0.0044
234 MATERNAL EXPOSURE DURING PREGNANCY 392 0.0044
235 DEMYELINATION 18 0.0044
236 EXTRAVASATION 18 0.0044
237 DRUG-INDUCED LIVER INJURY 136 0.0043
238 ACIDOSIS 33 0.0043
239 METABOLIC DISORDER 25 0.0043
240 CANCER PAIN 11 0.0043
241 MALNUTRITION 48 0.0043
242 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 222 0.0043
243 BRADYKINESIA 25 0.0042
244 NORMAL NEWBORN 23 0.0042
245 PUSTULE 10 0.0042
246 BRAIN OEDEMA 53 0.0042
247 BLOOD LACTIC ACID INCREASED 22 0.0042
248 COAGULOPATHY 69 0.0041
249 ENTEROCOCCAL INFECTION 20 0.0041
250 AREFLEXIA 11 0.0041
251 HYPOALBUMINAEMIA 32 0.0041
252 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
253 HYPOKALAEMIA 187 0.0040
254 MOUTH ULCERATION 84 0.0040
255 HYPERCAPNIA 12 0.0040
256 CARDIOMEGALY 49 0.0040
257 BLOOD LOSS ANAEMIA 9 0.0040
258 TEMPERATURE INTOLERANCE 41 0.0040
259 DISEASE COMPLICATION 18 0.0039
260 MUSCLE RIGIDITY 47 0.0039
261 SEDATION COMPLICATION 10 0.0039
262 ISCHAEMIA 18 0.0039
263 BLOOD CALCIUM DECREASED 44 0.0039
264 BLOOD ALBUMIN DECREASED 31 0.0039
265 CEREBRAL ISCHAEMIA 20 0.0039
266 BACTERAEMIA 46 0.0039
267 CATHETER SITE PAIN 10 0.0039
268 RED CELL DISTRIBUTION WIDTH INCREASED 16 0.0038
269 STAPHYLOCOCCAL SEPSIS 19 0.0038
270 VITILIGO 9 0.0038
271 ANURIA 33 0.0038
272 ESCHERICHIA BACTERAEMIA 9 0.0038
273 DRUG LEVEL INCREASED 63 0.0038
274 HAEMODYNAMIC INSTABILITY 29 0.0038
275 COMA SCALE ABNORMAL 11 0.0038
276 VASCULAR DEVICE INFECTION 17 0.0037
277 PRODUCT PACKAGING CONFUSION 9 0.0037
278 BRAIN INJURY 37 0.0037
279 HYPOCALCAEMIA 69 0.0036
280 PEPTIC ULCER 12 0.0036
281 MACULE 10 0.0036
282 STEVENS-JOHNSON SYNDROME 80 0.0036
283 APNOEA 28 0.0036
284 SECRETION DISCHARGE 45 0.0036
285 ABDOMINAL DISTENSION 374 0.0036
286 BRAIN NATRIURETIC PEPTIDE INCREASED 11 0.0036
287 LYMPHOCYTE COUNT DECREASED 63 0.0036
288 CAROTID ARTERY OCCLUSION 13 0.0036
289 BRAIN DEATH 11 0.0036
290 COVID-19 PNEUMONIA 42 0.0036
291 AGRANULOCYTOSIS 66 0.0035
292 SHOCK 81 0.0035
293 SINUS TACHYCARDIA 50 0.0035
294 ABSCESS LIMB 15 0.0035
295 PLATELET COUNT DECREASED 375 0.0035
296 HAEMOPTYSIS 98 0.0035
297 BLOOD CREATININE DECREASED 11 0.0035
298 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 18 0.0035
299 BLOOD CHOLESTEROL INCREASED 163 0.0035
300 GENERAL PHYSICAL HEALTH DETERIORATION 402 0.0035
301 BLOOD CREATININE ABNORMAL 12 0.0035
302 SKIN NECROSIS 18 0.0035
303 GENERALISED OEDEMA 42 0.0034
304 EUGLYCAEMIC DIABETIC KETOACIDOSIS 14 0.0034
305 EMBOLISM 28 0.0034
306 BLOOD MAGNESIUM DECREASED 29 0.0034
307 ELECTROLYTE IMBALANCE 39 0.0034
308 DEAFNESS NEUROSENSORY 11 0.0033
309 PROTHROMBIN TIME PROLONGED 20 0.0033
310 HYPERTONIA 19 0.0033
311 VARICES OESOPHAGEAL 10 0.0033
312 MONOCYTE COUNT INCREASED 12 0.0033
313 BLOOD PHOSPHORUS DECREASED 12 0.0033
314 PARKINSONISM 32 0.0033
315 BRONCHIECTASIS 22 0.0033
316 HYPOMAGNESAEMIA 45 0.0032
317 NEUTROPENIC SEPSIS 23 0.0032
318 SEPTIC SHOCK 140 0.0032
319 URINE OUTPUT DECREASED 28 0.0032
320 PLEURAL EFFUSION 194 0.0032
321 INFUSION SITE SWELLING 20 0.0032
322 MICTURITION DISORDER 11 0.0032
323 RESPIRATORY FAILURE 231 0.0032
324 HYPERTRANSAMINASAEMIA 22 0.0032
325 ANAL ABSCESS 17 0.0032
326 CARDIAC FAILURE ACUTE 21 0.0031
327 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
328 CONJUNCTIVITIS 58 0.0031
329 INITIAL INSOMNIA 32 0.0031
330 NEONATAL RESPIRATORY DISTRESS SYNDROME 11 0.0031
331 HYPOTONIA 31 0.0031
332 STILLBIRTH 15 0.0031
333 SINUS BRADYCARDIA 30 0.0031
334 SCOLIOSIS 19 0.0031
335 CHRONIC KIDNEY DISEASE 231 0.0030
336 SMALL FOR DATES BABY 15 0.0030
337 BLOOD POTASSIUM INCREASED 49 0.0030
338 PNEUMONIA ASPIRATION 75 0.0030
339 BLOOD CREATININE INCREASED 196 0.0030
340 FOETAL EXPOSURE DURING PREGNANCY 244 0.0030
341 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
342 TOXIC ENCEPHALOPATHY 15 0.0030
343 JOINT INJURY 63 0.0029
344 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 26 0.0029
345 CYTOPENIA 36 0.0029
346 IRON DEFICIENCY ANAEMIA 27 0.0029
347 ASPARTATE AMINOTRANSFERASE INCREASED 155 0.0029
348 KIDNEY TRANSPLANT REJECTION 14 0.0029
349 AUTOIMMUNE THYROIDITIS 11 0.0029
350 HYPERBILIRUBINAEMIA 30 0.0029
351 GUILLAIN-BARRE SYNDROME 14 0.0029
352 ACUTE PULMONARY OEDEMA 16 0.0028
353 SMALL INTESTINAL OBSTRUCTION 35 0.0028
354 PNEUMONIA VIRAL 9 0.0028
355 LEUKOCYTOSIS 51 0.0028
356 ORAL INFECTION 11 0.0028
357 CORONARY ARTERY DISEASE 85 0.0028
358 RESPIRATORY ACIDOSIS 11 0.0028
359 DIABETES MELLITUS 213 0.0028
360 SKIN EROSION 9 0.0028
361 TENSION HEADACHE 12 0.0028
362 LOWER RESPIRATORY TRACT INFECTION 126 0.0028
363 DYSPHORIA 14 0.0028
364 DRUG ERUPTION 49 0.0028
365 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
366 CYANOSIS 43 0.0027
367 LUNG INFILTRATION 24 0.0027
368 HIATUS HERNIA 35 0.0027
369 BLOOD BILIRUBIN INCREASED 73 0.0027
370 CARDIOVASCULAR DISORDER 68 0.0027
371 PERITONITIS BACTERIAL 27 0.0027
372 ANAPHYLACTOID REACTION 11 0.0027
373 HYPOTHERMIA 27 0.0027
374 VENTRICULAR TACHYCARDIA 44 0.0027
375 SUPRAVENTRICULAR EXTRASYSTOLES 9 0.0027
376 HYPOPHAGIA 68 0.0027
377 SUSPECTED OFF LABEL USE 12 0.0027
378 ILEUS 33 0.0027
379 HYPOTENSION 532 0.0026
380 BRADYCARDIA 140 0.0026
381 SWELLING 246 0.0026
382 TACHYCARDIA 233 0.0026
383 SLEEP TERROR 11 0.0026
384 DRY MOUTH 211 0.0026
385 HYPERAMMONAEMIA 13 0.0026
386 DEVICE RELATED INFECTION 40 0.0026
387 CYTOKINE RELEASE SYNDROME 52 0.0026
388 CARDIAC FAILURE CHRONIC 11 0.0026
389 SLEEP DISORDER 182 0.0026
390 UPPER RESPIRATORY TRACT INFECTION 119 0.0026
391 RESPIRATORY TRACT INFECTION 67 0.0026
392 RIGHT VENTRICULAR FAILURE 18 0.0026
393 LIVER FUNCTION TEST INCREASED 55 0.0026
394 ANAEMIA 486 0.0025
395 CANDIDA INFECTION 43 0.0025
396 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 15 0.0025
397 FIBRIN D DIMER INCREASED 9 0.0025
398 SPUTUM DISCOLOURED 24 0.0025
399 CONJUNCTIVAL HYPERAEMIA 9 0.0025
400 THROMBOSIS 202 0.0025
401 AZOTAEMIA 10 0.0025
402 SUBCUTANEOUS ABSCESS 12 0.0025
403 BODY TEMPERATURE INCREASED 51 0.0025
404 MOUTH HAEMORRHAGE 18 0.0025
405 SUBARACHNOID HAEMORRHAGE 25 0.0025
406 PERIPHERAL ISCHAEMIA 10 0.0024
407 HYPERURICAEMIA 10 0.0024
408 RESPIRATORY DISTRESS 67 0.0024
409 PULMONARY EMBOLISM 230 0.0024
410 CARDIAC DYSFUNCTION 9 0.0024
411 DISSEMINATED INTRAVASCULAR COAGULATION 34 0.0024
412 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
413 CARDIAC ARREST 197 0.0024
414 COLITIS ISCHAEMIC 16 0.0024
415 RESPIRATORY DEPRESSION 29 0.0024
416 MELAENA 52 0.0024
417 ACUTE HEPATIC FAILURE 32 0.0023
418 ABDOMINAL PAIN 544 0.0023
419 FULL BLOOD COUNT DECREASED 47 0.0023
420 PERITONEAL DIALYSIS COMPLICATION 17 0.0023
421 PULMONARY OEDEMA 104 0.0023
422 POLYURIA 19 0.0023
423 POOR VENOUS ACCESS 24 0.0023
424 INTENTIONAL PRODUCT MISUSE 203 0.0023
425 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 127 0.0023
426 RHINOVIRUS INFECTION 9 0.0023
427 TRANSIENT ISCHAEMIC ATTACK 78 0.0023
428 HYPOVOLAEMIC SHOCK 11 0.0023
429 UNRESPONSIVE TO STIMULI 59 0.0023
430 FEBRILE NEUTROPENIA 151 0.0023
431 LARYNGEAL OEDEMA 14 0.0023
432 ARTERIOSCLEROSIS CORONARY ARTERY 15 0.0023
433 ATRIAL FLUTTER 18 0.0023
434 CREATININE RENAL CLEARANCE DECREASED 9 0.0022
435 DRUG INTOLERANCE 216 0.0022
436 SKIN INFECTION 25 0.0022
437 HEPATIC FAILURE 67 0.0022
438 THROMBOCYTOPENIA 246 0.0022
439 MULTI-ORGAN FAILURE 38 0.0022
440 RENAL FAILURE 290 0.0022
441 ORAL DISORDER 16 0.0022
442 MENTAL STATUS CHANGES 60 0.0022
443 DIABETES MELLITUS INADEQUATE CONTROL 38 0.0021
444 ADRENAL INSUFFICIENCY 26 0.0021
445 UPPER GASTROINTESTINAL HAEMORRHAGE 36 0.0021
446 SKIN ABRASION 10 0.0021
447 PYREXIA 731 0.0021
448 NEUROTOXICITY 37 0.0021
449 CARDIAC TAMPONADE 10 0.0021
450 GESTATIONAL DIABETES 10 0.0021
451 BLOOD ALKALINE PHOSPHATASE INCREASED 52 0.0021
452 PRODUCT PREPARATION ERROR 43 0.0021
453 INTENTIONAL OVERDOSE 134 0.0021
454 METASTATIC NEOPLASM 9 0.0021
455 ASPHYXIA 17 0.0021
456 DIABETIC KETOACIDOSIS 50 0.0021
457 PULMONARY MASS 31 0.0021
458 RENAL FAILURE CHRONIC 16 0.0021
459 HORDEOLUM 9 0.0021
460 ENTEROCOLITIS 12 0.0021
461 BLOOD SODIUM DECREASED 39 0.0021
462 UROSEPSIS 19 0.0021
463 PERIPHERAL SENSORY NEUROPATHY 12 0.0021
464 VOMITING 963 0.0020
465 ABDOMINAL TENDERNESS 10 0.0020
466 PANCREATITIS ACUTE 45 0.0020
467 RENAL IMPAIRMENT 168 0.0020
468 FLUID OVERLOAD 29 0.0020
469 ALANINE AMINOTRANSFERASE INCREASED 122 0.0020
470 MUCOSAL INFLAMMATION 52 0.0020
471 ASPERGILLUS INFECTION 13 0.0020
472 IMPAIRED GASTRIC EMPTYING 27 0.0020
473 KLEBSIELLA INFECTION 10 0.0020
474 TUBULOINTERSTITIAL NEPHRITIS 37 0.0020
475 CONSTIPATION 429 0.0020
476 AMMONIA INCREASED 10 0.0020
477 DYSPHAGIA 186 0.0020
478 LEUKOPENIA 98 0.0020
479 STATUS EPILEPTICUS 22 0.0019
480 DEPRESSED LEVEL OF CONSCIOUSNESS 77 0.0019
481 PERICARDIAL EFFUSION 45 0.0019
482 OXYGEN SATURATION DECREASED 109 0.0019
483 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
484 ATAXIA 23 0.0019
485 FAILURE TO THRIVE 10 0.0019
486 RED BLOOD CELL COUNT DECREASED 55 0.0019
487 PURPURA 17 0.0019
488 TORSADE DE POINTES 15 0.0019
489 PRODUCTIVE COUGH 91 0.0019
490 PRODUCT USE IN UNAPPROVED INDICATION 471 0.0019
491 HAEMORRHAGE INTRACRANIAL 28 0.0019
492 HYPERCALCAEMIA 23 0.0019
493 NEUTROPHIL COUNT INCREASED 19 0.0019
494 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16 0.0018
495 CHEST DISCOMFORT 188 0.0018
496 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31 0.0018
497 SEROTONIN SYNDROME 35 0.0018
498 HEPATIC ENCEPHALOPATHY 17 0.0018
499 ABSCESS 29 0.0018
500 MUSCLE ATROPHY 23 0.0018
501 BLOOD PRESSURE DECREASED 120 0.0018
502 RESPIRATORY RATE INCREASED 16 0.0018
503 PALLOR 49 0.0018
504 RASH ERYTHEMATOUS 86 0.0018
505 DERMATITIS EXFOLIATIVE 9 0.0018
506 PULMONARY HAEMORRHAGE 14 0.0018
507 ORTHOSTATIC HYPOTENSION 31 0.0018
508 DERMATITIS CONTACT 20 0.0018
509 PNEUMONIA BACTERIAL 16 0.0017
510 KETOACIDOSIS 13 0.0017
511 HAEMATEMESIS 44 0.0017
512 GASTROINTESTINAL DISORDER 155 0.0017
513 SKIN WARM 10 0.0017
514 ERYTHEMA MULTIFORME 16 0.0017
515 NEPHROPATHY 16 0.0017
516 HEMIPARESIS 29 0.0017
517 HAEMOGLOBIN ABNORMAL 11 0.0017
518 BLOOD LACTATE DEHYDROGENASE INCREASED 27 0.0017
519 HYPERTHERMIA 13 0.0017
520 PANCYTOPENIA 95 0.0017
521 LIVER DISORDER 75 0.0017
522 EXPOSURE DURING PREGNANCY 105 0.0017
523 PRODUCT ADMINISTRATION ERROR 34 0.0017
524 ANAPHYLACTIC SHOCK 43 0.0017
525 GASTROENTERITIS 24 0.0016
526 DRUG LEVEL BELOW THERAPEUTIC 9 0.0016
527 BLOOD POTASSIUM DECREASED 49 0.0016
528 HAEMOGLOBIN DECREASED 167 0.0016
529 BLOOD PRESSURE DIASTOLIC DECREASED 12 0.0016
530 CONDITION AGGRAVATED 494 0.0016
531 OEDEMA PERIPHERAL 197 0.0016
532 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
533 BLISTER 90 0.0016
534 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
535 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
536 RESPIRATORY ARREST 44 0.0016
537 PULMONARY HYPERTENSION 33 0.0016
538 HICCUPS 13 0.0016
539 PNEUMONITIS 43 0.0016
540 ATRIAL FIBRILLATION 153 0.0016
541 FACIAL PAIN 14 0.0016
542 DYSPNOEA EXERTIONAL 59 0.0016
543 CYTOMEGALOVIRUS INFECTION 26 0.0016
544 ENTERITIS 10 0.0016
545 PAPULE 11 0.0016
546 ANAL INCONTINENCE 14 0.0016
547 CHILLS 182 0.0016
548 INFUSION SITE ERYTHEMA 13 0.0015
549 VENTRICULAR EXTRASYSTOLES 16 0.0015
550 OEDEMA 83 0.0015
551 GRAFT VERSUS HOST DISEASE 11 0.0015
552 URINARY RETENTION 51 0.0015
553 ORAL CANDIDIASIS 20 0.0015
554 SOMNOLENCE 305 0.0015
555 TOXICITY TO VARIOUS AGENTS 255 0.0015
556 RHABDOMYOLYSIS 63 0.0015
557 HYPERTENSION 315 0.0015
558 RASH MACULO-PAPULAR 33 0.0015
559 DIALYSIS 21 0.0015
560 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
561 DECUBITUS ULCER 12 0.0015
562 COMA 70 0.0015
563 DRUG TOXICITY 20 0.0015
564 SUBDURAL HAEMATOMA 21 0.0015
565 ECCHYMOSIS 10 0.0015
566 CHOLANGITIS 9 0.0015
567 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
568 RENAL INJURY 43 0.0014
569 INSURANCE ISSUE 22 0.0014
570 CARDIO-RESPIRATORY ARREST 60 0.0014
571 LIVE BIRTH 12 0.0014
572 PNEUMONIA 464 0.0014
573 FEEDING DISORDER 29 0.0014
574 HAEMOLYSIS 11 0.0014
575 THERAPY NON-RESPONDER 64 0.0014
576 ELECTROCARDIOGRAM QT PROLONGED 51 0.0014
577 RENAL FAILURE ACUTE 60 0.0014
578 DYSURIA 52 0.0014
579 HAEMATOCRIT DECREASED 28 0.0014
580 C-REACTIVE PROTEIN INCREASED 51 0.0014
581 INFUSION SITE PAIN 18 0.0014
582 STAPHYLOCOCCAL INFECTION 46 0.0014
583 INFUSION RELATED REACTION 92 0.0014
584 RENAL CYST 11 0.0014
585 ARTERIOSCLEROSIS 13 0.0014
586 CAESAREAN SECTION 16 0.0014
587 DEHYDRATION 183 0.0014
588 PULMONARY CONGESTION 18 0.0014
589 APPETITE DISORDER 9 0.0014
590 ACUTE MYOCARDIAL INFARCTION 40 0.0014
591 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
592 DERMATITIS ALLERGIC 17 0.0014
593 SHOCK HAEMORRHAGIC 11 0.0013
594 CARDIOTOXICITY 12 0.0013
595 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
596 HYPERAESTHESIA 11 0.0013
597 WRONG PRODUCT ADMINISTERED 9 0.0013
598 DEMENTIA 37 0.0013
599 NAUSEA 1037 0.0013
600 LIPASE INCREASED 10 0.0013
601 MUSCLE SPASTICITY 16 0.0013
602 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
603 INTERSTITIAL LUNG DISEASE 63 0.0013
604 DECREASED APPETITE 297 0.0013
605 MULTIPLE ALLERGIES 10 0.0013
606 SEASONAL ALLERGY 18 0.0013
607 CARDIAC FAILURE CONGESTIVE 102 0.0013
608 SKIN SWELLING 11 0.0013
609 GASTROOESOPHAGEAL REFLUX DISEASE 102 0.0013
610 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
611 MUSCLE TWITCHING 29 0.0013
612 HEPATOTOXICITY 28 0.0013
613 CYSTITIS 40 0.0013
614 MUSCULOSKELETAL STIFFNESS 110 0.0013
615 GROIN PAIN 11 0.0013
616 CHOLESTASIS 24 0.0012
617 TENDERNESS 13 0.0012
618 IMMUNOSUPPRESSION 11 0.0012
619 OFF LABEL USE 1091 0.0012
620 FACE OEDEMA 21 0.0012
621 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
622 LUNG DISORDER 61 0.0012
623 COLITIS 47 0.0012
624 HEART RATE INCREASED 121 0.0012
625 OESOPHAGEAL CARCINOMA 36 0.0012
626 CELLULITIS 61 0.0012
627 DYSPNOEA 683 0.0012
628 VASCULITIS 14 0.0012
629 PULMONARY FIBROSIS 23 0.0012
630 HYPERHIDROSIS 154 0.0012
631 ANAPHYLACTIC REACTION 66 0.0012
632 OBESITY 19 0.0012
633 BRONCHOSPASM 17 0.0012
634 HAEMODIALYSIS 10 0.0012
635 DRUG INTERACTION 188 0.0012
636 ARRHYTHMIA 56 0.0012
637 RETCHING 25 0.0012
638 OSTEOPOROSIS 48 0.0012
639 PSEUDOMONAS INFECTION 10 0.0012
640 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
641 NEPHROPATHY TOXIC 13 0.0012
642 INTESTINAL PERFORATION 13 0.0012
643 DEEP VEIN THROMBOSIS 75 0.0012
644 CARDIOMYOPATHY 17 0.0011
645 PETECHIAE 12 0.0011
646 CEREBRAL INFARCTION 28 0.0011
647 TRANSFUSION 12 0.0011
648 CARDIAC FAILURE 91 0.0011
649 TRICUSPID VALVE INCOMPETENCE 9 0.0011
650 GINGIVAL PAIN 9 0.0011
651 WHEEZING 67 0.0011
652 LETHARGY 65 0.0011
653 HYPOAESTHESIA ORAL 17 0.0011
654 INTERNATIONAL NORMALISED RATIO INCREASED 32 0.0011
655 BODY TEMPERATURE DECREASED 11 0.0011
656 DYSARTHRIA 42 0.0011
657 INTESTINAL OBSTRUCTION 42 0.0011
658 SINUSITIS 114 0.0011
659 PERITONITIS 23 0.0011
660 SEDATION 29 0.0011
661 OROPHARYNGEAL DISCOMFORT 10 0.0011
662 BLOOD PRESSURE ABNORMAL 22 0.0011
663 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
664 BLOOD GLUCOSE DECREASED 53 0.0011
665 NEUTROPENIA 150 0.0011
666 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
667 EAR INFECTION 29 0.0011
668 GRAND MAL CONVULSION 10 0.0011
669 ASTHENIA 407 0.0011
670 EOSINOPHIL COUNT INCREASED 9 0.0011
671 HEPATIC STEATOSIS 20 0.0011
672 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
673 RASH PAPULAR 24 0.0011
674 CHOLELITHIASIS 35 0.0011
675 LACERATION 10 0.0011
676 MITRAL VALVE INCOMPETENCE 12 0.0011
677 SYNCOPE 106 0.0011
678 MUSCULAR WEAKNESS 120 0.0011
679 FACIAL PARALYSIS 9 0.0011
680 HEPATITIS 27 0.0011
681 WEIGHT FLUCTUATION 11 0.0011
682 DISCOMFORT 64 0.0010
683 PARALYSIS 15 0.0010
684 URINARY INCONTINENCE 31 0.0010
685 PYELONEPHRITIS 9 0.0010
686 HYPOKINESIA 15 0.0010
687 BRAIN FOG 16 0.0010
688 SKIN LESION 28 0.0010
689 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
690 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
691 CHOLECYSTITIS 12 0.0010
692 GASTROINTESTINAL INFECTION 9 0.0010
693 MYOSITIS 9 0.0010
694 LIVER FUNCTION TEST ABNORMAL 29 0.0010
695 SEIZURE 115 0.0010
696 ASTHMA 112 0.0010
697 PANCREATITIS 52 0.0010
698 INJECTION SITE EXTRAVASATION 12 0.0010
699 HYPOTHYROIDISM 31 0.0010
700 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
701 PRODUCT PRESCRIBING ISSUE 21 0.0010
702 COGNITIVE DISORDER 45 0.0010
703 FUNGAL INFECTION 32 0.0010
704 GINGIVAL BLEEDING 13 0.0010
705 TYPE 2 DIABETES MELLITUS 32 0.0009
706 IMMUNODEFICIENCY 14 0.0009
707 EPISTAXIS 70 0.0009
708 EAR PAIN 18 0.0009
709 THROAT TIGHTNESS 25 0.0009
710 PHARYNGITIS STREPTOCOCCAL 10 0.0009
711 ECONOMIC PROBLEM 14 0.0009
712 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
713 PRURITUS 353 0.0009
714 HEPATOMEGALY 9 0.0009
715 WHITE BLOOD CELL COUNT INCREASED 35 0.0009
716 SARS-COV-2 TEST POSITIVE 12 0.0009
717 HAEMATURIA 31 0.0009
718 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 21 0.0009
719 NERVE INJURY 10 0.0009
720 FEELING COLD 25 0.0009
721 PROTEINURIA 17 0.0009
722 NEUROPATHY PERIPHERAL 85 0.0009
723 DELIRIUM 31 0.0009
724 PERICARDITIS 15 0.0009
725 JAUNDICE 24 0.0009
726 EYE INFECTION 10 0.0009
727 DRUG LEVEL DECREASED 9 0.0009
728 MEDICATION ERROR 49 0.0009
729 RESPIRATORY TRACT CONGESTION 14 0.0009
730 URINARY TRACT INFECTION 150 0.0009
731 NASAL CONGESTION 51 0.0009
732 RHINORRHOEA 56 0.0009
733 FLUSHING 88 0.0009
734 PALPITATIONS 100 0.0009
735 DEVICE OCCLUSION 12 0.0009
736 INFLAMMATION 44 0.0009
737 LYMPHOPENIA 12 0.0008
738 COUGH 235 0.0008
739 ANHEDONIA 22 0.0008
740 RESPIRATORY DISORDER 25 0.0008
741 ANOSMIA 12 0.0008
742 HYPERTHYROIDISM 12 0.0008
743 OSTEOMYELITIS 15 0.0008
744 SKIN LACERATION 9 0.0008
745 LOSS OF CONSCIOUSNESS 106 0.0008
746 ERYTHEMA 170 0.0008
747 BURSITIS 10 0.0008
748 MOBILITY DECREASED 59 0.0008
749 SKIN ULCER 21 0.0008
750 HEPATIC ENZYME INCREASED 55 0.0008
751 RASH MACULAR 28 0.0008
752 ABORTION SPONTANEOUS 32 0.0008
753 HEPATIC CIRRHOSIS 15 0.0008
754 RASH PRURITIC 43 0.0008
755 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
756 TREMOR 131 0.0008
757 BONE MARROW FAILURE 16 0.0008
758 MYOCARDITIS 9 0.0008
759 EPILEPSY 24 0.0008
760 FAECES DISCOLOURED 17 0.0008
761 LIP SWELLING 26 0.0008
762 HYPOAESTHESIA 116 0.0008
763 POST PROCEDURAL HAEMORRHAGE 9 0.0008
764 ANGIOEDEMA 34 0.0008
765 SPLENOMEGALY 9 0.0008
766 ACCIDENTAL OVERDOSE 28 0.0008
767 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
768 DERMATITIS 16 0.0008
769 GASTRITIS 20 0.0008
770 PNEUMOTHORAX 12 0.0008
771 MYOCLONUS 9 0.0008
772 ECZEMA 39 0.0007
773 DIARRHOEA 481 0.0007
774 COVID-19 130 0.0007
775 SINUS CONGESTION 10 0.0007
776 METASTASES TO LIVER 13 0.0007
777 DRUG INEFFECTIVE 973 0.0007
778 HALLUCINATION 55 0.0007
779 POST PROCEDURAL COMPLICATION 14 0.0007
780 ISCHAEMIC STROKE 13 0.0007
781 FEELING HOT 44 0.0007
782 ORAL PAIN 16 0.0007
783 KIDNEY INFECTION 14 0.0007
784 INFECTION 103 0.0007
785 MUSCULOSKELETAL CHEST PAIN 11 0.0007
786 RESTLESSNESS 26 0.0007
787 LUNG INFECTION 11 0.0007
788 EJECTION FRACTION DECREASED 11 0.0007
789 HEPATOCELLULAR INJURY 10 0.0007
790 NERVOUS SYSTEM DISORDER 22 0.0007
791 EATING DISORDER 15 0.0007
792 RASH 307 0.0007
793 MYDRIASIS 9 0.0007
794 TINNITUS 32 0.0007
795 APHASIA 21 0.0007
796 BLOOD GLUCOSE INCREASED 131 0.0007
797 HAEMATOMA 18 0.0007
798 CHEST PAIN 128 0.0007
799 BLINDNESS 28 0.0007
800 COLD SWEAT 12 0.0007
801 DISEASE PROGRESSION 80 0.0007
802 INTENTIONAL PRODUCT USE ISSUE 58 0.0007
803 ABDOMINAL PAIN UPPER 136 0.0007
804 OROPHARYNGEAL PAIN 61 0.0007
805 HEART RATE DECREASED 23 0.0007
806 DIPLOPIA 17 0.0007
807 BLOOD PRESSURE INCREASED 100 0.0007
808 AGITATION 48 0.0007
809 OVERDOSE 140 0.0006
810 CEREBRAL HAEMORRHAGE 23 0.0006
811 TREATMENT NONCOMPLIANCE 35 0.0006
812 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 114 0.0006
813 CHROMATURIA 14 0.0006
814 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
815 MUSCLE TIGHTNESS 10 0.0006
816 PRESYNCOPE 15 0.0006
817 HAEMORRHOIDS 12 0.0006
818 DISORIENTATION 24 0.0006
819 PAIN IN JAW 17 0.0006
820 DYSPHONIA 35 0.0006
821 BONE PAIN 35 0.0006
822 MENTAL DISORDER 26 0.0006
823 DIZZINESS 297 0.0006
824 PAIN OF SKIN 16 0.0006
825 BACK PAIN 138 0.0006
826 PRODUCT USE ISSUE 111 0.0006
827 DYSKINESIA 24 0.0006
828 FALL 196 0.0006
829 MALIGNANT NEOPLASM PROGRESSION 60 0.0006
830 STOMATITIS 35 0.0006
831 THERAPY PARTIAL RESPONDER 9 0.0006
832 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
833 INCREASED APPETITE 11 0.0006
834 WOUND 16 0.0006
835 MALAISE 251 0.0006
836 MYALGIA 97 0.0006
837 CONFUSIONAL STATE 92 0.0006
838 ORAL HERPES 11 0.0006
839 ILLNESS 58 0.0006
840 HAEMATOCHEZIA 31 0.0006
841 SUICIDE ATTEMPT 34 0.0006
842 INFLUENZA 62 0.0006
843 INJURY 39 0.0006
844 SWELLING FACE 36 0.0006
845 LIMB INJURY 15 0.0006
846 RESTLESS LEGS SYNDROME 10 0.0005
847 HEADACHE 344 0.0005
848 SKIN EXFOLIATION 46 0.0005
849 BLOOD GLUCOSE ABNORMAL 10 0.0005
850 VIRAL INFECTION 18 0.0005
851 EMOTIONAL DISTRESS 65 0.0005
852 LYMPHADENOPATHY 19 0.0005
853 RIB FRACTURE 11 0.0005
854 BRONCHITIS 39 0.0005
855 GASTRIC ULCER 10 0.0005
856 PERIPHERAL SWELLING 81 0.0005
857 SCAR 9 0.0005
858 MUSCULOSKELETAL DISORDER 10 0.0005
859 FATIGUE 408 0.0005
860 ANKLE FRACTURE 8 0.0005
861 HAEMORRHAGE 54 0.0005
862 SYRINGE ISSUE 9 0.0005
863 PAIN 310 0.0005
864 SKIN DISCOLOURATION 23 0.0005
865 DRUG EXPOSURE DURING PREGNANCY 17 0.0005
866 PREGNANCY 10 0.0005
867 FLUID RETENTION 25 0.0005
868 PLASMA CELL MYELOMA 19 0.0005
869 FEMUR FRACTURE 15 0.0005
870 POLLAKIURIA 20 0.0005
871 DYSSTASIA 14 0.0005
872 ABDOMINAL DISCOMFORT 80 0.0005
873 BLOOD URINE PRESENT 9 0.0005
874 NECK PAIN 26 0.0005
875 JOINT SWELLING 56 0.0005
876 PRODUCT DOSE OMISSION ISSUE 136 0.0005
877 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
878 DEATH 397 0.0005
879 DEPRESSION 104 0.0005
880 LOCALISED INFECTION 11 0.0005
881 SINUS DISORDER 9 0.0005
882 LIMB DISCOMFORT 14 0.0005
883 EXPIRED PRODUCT ADMINISTERED 15 0.0005
884 EYE PRURITUS 15 0.0004
885 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
886 ABDOMINAL PAIN LOWER 11 0.0004
887 GASTRIC CANCER 11 0.0004
888 NEOPLASM PROGRESSION 15 0.0004
889 DRUG RESISTANCE 11 0.0004
890 URTICARIA 71 0.0004
891 PRODUCT PRESCRIBING ERROR 10 0.0004
892 CATARACT 25 0.0004
893 POOR QUALITY SLEEP 9 0.0004
894 NASOPHARYNGITIS 77 0.0004
895 WEIGHT DECREASED 116 0.0004
896 ANXIETY 118 0.0004
897 MENTAL IMPAIRMENT 10 0.0004
898 PAIN IN EXTREMITY 121 0.0004
899 HYPERSENSITIVITY 76 0.0004
900 SNEEZING 9 0.0004
901 AGEUSIA 10 0.0004
902 DISEASE RECURRENCE 19 0.0004
903 TREATMENT FAILURE 33 0.0004
904 MIGRAINE 38 0.0004
905 DIVERTICULITIS 11 0.0004
906 NEPHROLITHIASIS 18 0.0004
907 MUSCLE SPASMS 72 0.0004
908 SKIN DISORDER 13 0.0004
909 VISUAL IMPAIRMENT 48 0.0004
910 HYPERSOMNIA 11 0.0004
911 ROAD TRAFFIC ACCIDENT 16 0.0004
912 SPEECH DISORDER 20 0.0004
913 OCULAR HYPERAEMIA 18 0.0004
914 ARTHRALGIA 156 0.0004
915 PARAESTHESIA 59 0.0004
916 NIGHT SWEATS 12 0.0004
917 HYPOACUSIS 16 0.0004
918 VISION BLURRED 51 0.0004
919 CONVULSION 21 0.0004
920 DYSPEPSIA 36 0.0004
921 GAIT DISTURBANCE 70 0.0004
922 HERPES ZOSTER 21 0.0004
923 UNDERDOSE 26 0.0004
924 SWOLLEN TONGUE 11 0.0004
925 RECTAL HAEMORRHAGE 15 0.0003
926 HEAD INJURY 11 0.0003
927 RENAL DISORDER 16 0.0003
928 CONTUSION 33 0.0003
929 INSOMNIA 91 0.0003
930 EYE PAIN 19 0.0003
931 ADVERSE EVENT 31 0.0003
932 HOSPITALISATION 51 0.0003
933 LACRIMATION INCREASED 10 0.0003
934 CEREBROVASCULAR ACCIDENT 55 0.0003
935 BALANCE DISORDER 28 0.0003
936 EYE SWELLING 12 0.0003
937 HOT FLUSH 24 0.0003
938 LUNG NEOPLASM MALIGNANT 13 0.0003
939 DISTURBANCE IN ATTENTION 17 0.0003
940 BURNING SENSATION 22 0.0003
941 PANCREATIC CARCINOMA 9 0.0003
942 MOVEMENT DISORDER 10 0.0003
943 LABORATORY TEST ABNORMAL 9 0.0003
944 FEELING ABNORMAL 73 0.0003
945 VAGINAL HAEMORRHAGE 13 0.0003
946 VERTIGO 18 0.0003
947 DRUG ADMINISTRATION ERROR 9 0.0003
948 NO ADVERSE EVENT 53 0.0003
949 MYOCARDIAL INFARCTION 51 0.0003
950 MUSCULOSKELETAL PAIN 15 0.0003
951 DEPRESSED MOOD 15 0.0003
952 OSTEOARTHRITIS 12 0.0003
953 FLATULENCE 16 0.0003
954 WEIGHT INCREASED 63 0.0003
955 ABNORMAL BEHAVIOUR 11 0.0003
956 AMNESIA 18 0.0003
957 CRYING 10 0.0003
958 EYE DISORDER 9 0.0003
959 DRUG DEPENDENCE 44 0.0003
960 GAIT INABILITY 9 0.0003
961 ALOPECIA 50 0.0003
962 THROAT IRRITATION 11 0.0002
963 DYSGEUSIA 18 0.0002
964 CARDIAC DISORDER 22 0.0002
965 DRY SKIN 31 0.0002
966 INCORRECT DOSE ADMINISTERED 53 0.0002
967 DEVICE LEAKAGE 10 0.0002
968 THERAPY INTERRUPTED 16 0.0002
969 IRRITABILITY 13 0.0002
970 MEMORY IMPAIRMENT 29 0.0002
971 SURGERY 12 0.0002
972 COLITIS ULCERATIVE 9 0.0002
973 DRY EYE 10 0.0002
974 NEOPLASM MALIGNANT 13 0.0002
975 INFLUENZA LIKE ILLNESS 16 0.0002
976 THERAPEUTIC RESPONSE DECREASED 11 0.0002
977 ILL-DEFINED DISORDER 11 0.0002
978 UNEVALUABLE EVENT 12 0.0002
979 PRODUCT QUALITY ISSUE 20 0.0001
980 INJECTION SITE ERYTHEMA 18 0.0001
981 BREAST CANCER 13 0.0001
982 DEVICE MALFUNCTION 9 0.0001
983 ARTHRITIS 10 0.0001
984 DEVICE ISSUE 11 0.0001
985 PSORIASIS 16 0.0001
986 ADVERSE DRUG REACTION 11 0.0001
987 SUICIDAL IDEATION 11 0.0001
988 DRUG ABUSE 10 0.0001
989 INJECTION SITE PAIN 32 0.0001
990 RHEUMATOID ARTHRITIS 10 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
992 DRUG DOSE OMISSION 12 0.0001
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001